Author: Mohammadipoor, Arezoo; Antebi, Ben; Batchinsky, Andriy I.; Cancio, Leopoldo C.
Title: Therapeutic potential of products derived from mesenchymal stem/stromal cells in pulmonary disease Cord-id: f7ql6qjv Document date: 2018_11_9
ID: f7ql6qjv
Snippet: Multipotent mesenchymal stem/stromal cells (MSCs) possess robust self-renewal characteristics and the ability to differentiate into tissue-specific cells. Their therapeutic potential appears promising as evident from their efficacy in several animal models of pulmonary disorders as well as early-phase clinical trials of acute respiratory distress syndrome (ARDS) and chronic obstructive pulmonary disease (COPD). Such therapeutic efficacy might be attributed to MSC-derived products (the “secreto
Document: Multipotent mesenchymal stem/stromal cells (MSCs) possess robust self-renewal characteristics and the ability to differentiate into tissue-specific cells. Their therapeutic potential appears promising as evident from their efficacy in several animal models of pulmonary disorders as well as early-phase clinical trials of acute respiratory distress syndrome (ARDS) and chronic obstructive pulmonary disease (COPD). Such therapeutic efficacy might be attributed to MSC-derived products (the “secretomeâ€), namely conditioned media (CM) and extracellular vesicles (EVs), which have been shown to play pivotal roles in the regenerative function of MSCs. Importantly, the EVs secreted by MSCs can transfer a variety of bioactive factors to modulate the function of recipient cells via various mechanisms, including ligand-receptor interactions, direct membrane fusion, endocytosis, or phagocytosis. Herein, we review the current state-of-the-science of MSC-derived CM and EVs as potential therapeutic agents in lung diseases. We suggest that the MSC-derived secretome might be an appropriate therapeutic agent for treating aggressive pulmonary disorders because of biological and logistical advantages over live cell therapy. Nonetheless, further studies are warranted to elucidate the safety and efficacy of these components in combating pulmonary diseases.
Search related documents:
Co phrase search for related documents- absence presence and activator signal transducer: 1
- absence presence and acute ali lung injury: 1, 2, 3
- absence presence and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- absence presence and adipose tissue: 1, 2, 3, 4, 5
- absence presence and local delivery: 1
- absence presence and long storage: 1, 2
- absence presence and low amount: 1
- absence presence and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- absence presence and lung endothelial: 1
- absence presence and lung fibroblast: 1
- absence presence and lung function: 1, 2
- absence presence and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9
- absence presence and lung injury: 1, 2, 3, 4
- absence presence and lung injury model: 1, 2
- absence presence and lung macrophage: 1
- absence presence and lung parenchyma: 1
- absence presence and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8
- absence presence and lung weight: 1, 2
- absence presence and macrophage inflammatory: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date